Published in Virology on December 01, 1972
The dengue viruses. Clin Microbiol Rev (1990) 4.72
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol (1989) 2.38
Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol (1992) 2.33
Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. J Virol (1987) 1.72
Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence. J Virol (1998) 1.34
Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J Virol (2001) 1.33
Dengue virus-induced modifications of host cell membranes. J Virol (1975) 1.33
Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J Virol (1988) 1.29
Cytological localization of Dengue-2 antigens: an immunological study with ultrastructural correlation. Infect Immun (1973) 1.26
Resuscitating mutations in a furin cleavage-deficient mutant of the flavivirus tick-borne encephalitis virus. J Virol (2005) 1.02
Replication of dengue virus type 2 in Aedes albopictus cell culture. J Virol (1973) 0.88
Virion and soluble antigens of japanese encephalitis virus. Infect Immun (1975) 0.86
Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly. J Virol (2012) 0.82
Unique peptide maps of the three largest proteins specified by the flavivirus Kunjin. J Virol (1977) 0.79
Ultrastructural studies on dengue virus infection of human lymphoblasts. Infect Immun (1978) 0.78
Comparisons of the peptide maps of Kunjin virus proteins smaller than the envelope protein. J Virol (1977) 0.78
Effects of 2-deoxy-D-glucose and 3 deazauridine individually and in combination on the replication of Japanese B encephalitis virus. Antimicrob Agents Chemother (1977) 0.77
A Single Amino Acid Substitution in the M Protein Attenuates Japanese Encephalitis Virus in Mammalian Hosts. J Virol (2015) 0.77
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96
Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med (1993) 7.29
Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06
Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol (1989) 7.06
A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50
Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg (1982) 4.04
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J Exp Med (1993) 3.48
Flaviviridae. Intervirology (1985) 3.06
Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg (1967) 2.61
Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57
Cardiovascular thrombotic events in controlled, clinical trials of rofecoxib. Circulation (2001) 2.55
Bunyaviridae. Intervirology (1980) 2.53
Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45
Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg (1982) 2.41
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther (2004) 2.38
Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04
Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest (1966) 2.01
Togaviridae. Intervirology (1985) 1.96
Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am J Trop Med Hyg (1983) 1.96
Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95
Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94
Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Low-back pain in pregnancy. Spine (Phila Pa 1976) (1987) 1.84
Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80
Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79
Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood. Science (1967) 1.78
Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2007) 1.75
Physical and biological properties of dengue-2 virus and associated antigens. J Virol (1970) 1.75
Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys (1992) 1.73
Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71
Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69
Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect Immun (1982) 1.69
An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg (1968) 1.68
Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun (1980) 1.67
Immunological and biophysical separation of dengue-2 antigens. J Virol (1971) 1.66
Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Virol (1984) 1.66
Anti-dengue immunoglobulins and serum beta 1 c-a globulin levels in dengue shock syndrome. J Immunol (1969) 1.64
The proteins of Japanese encephalitis virus. Virology (1971) 1.63
Isolation and characterization of glucocerebrosidase from human placental tissue. J Biol Chem (1973) 1.62
An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med (1967) 1.61
Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells. Mol Cell Biol (1985) 1.61
Evidence for two mechanisms of dengue virus infection of adherent human monocytes: trypsin-sensitive virus receptors and trypsin-resistant immune complex receptors. Infect Immun (1981) 1.58
Bunyaviruses and Bunyaviridae. Intervirology (1976) 1.58
Decreased systolic blood pressure through operant conditioning techniques in patients with essential hypertension. Science (1971) 1.54
Virulence and immunogenicity of a temperature-sensitive dengue-2 virus in lower primates. Infect Immun (1977) 1.51
Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J (1991) 1.50
Antibody response in dengue and dengue hemorrhagic fever. Jpn J Med Sci Biol (1967) 1.47
Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci U S A (1993) 1.45
Blood pressure morning surge and hostility. Am J Hypertens (1998) 1.45
MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. J Leukoc Biol (1999) 1.44
Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes. Infect Immun (1979) 1.44
Experimental infection of chimpanzees with dengue viruses. Am J Trop Med Hyg (1978) 1.39
Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis (1977) 1.39
Craniofacial injuries resulting from taxicab accidents in New York City. Ann Plast Surg (1996) 1.38
Swine influenza A at Fort Dix, New Jersey (January-February 1976). III. Extent of spread and duration of the outbreak. J Infect Dis (1977) 1.38
Partial purification and characterization of a dengue virus soluble complement-fixing antigen. J Immunol (1970) 1.37
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury. Am J Transplant (2007) 1.36
Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines. Am J Epidemiol (1971) 1.36
Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg (1970) 1.33
Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis (1971) 1.33
Negative dental experiences and their relationship to dental anxiety. Community Dent Health (1996) 1.32
Pain inhibition, nicotine, and gender. Exp Clin Psychopharmacol (1998) 1.31
Antigenic components of group A arbovirus virions. J Virol (1973) 1.30
Dengue virions and antigens in brain and serum of infected mice. J Virol (1970) 1.30
Human immunoglobulin specificity after group B arbovirus infections. Infect Immun (1972) 1.29
Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun (1981) 1.28
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. Int J Obes (Lond) (2010) 1.28
Dengue-2 vaccine: viremia and immune responses in rhesus monkeys. Infect Immun (1980) 1.27
Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis (1983) 1.27
Age of onset of dental anxiety. J Dent Res (1999) 1.26
Cytological localization of Dengue-2 antigens: an immunological study with ultrastructural correlation. Infect Immun (1973) 1.26
The metabolism of sphingomyelin. I. Purification and properties of a sphingomyelin-cleaving enzyme from rat liver tissue. J Biol Chem (1966) 1.25
Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan. Am J Trop Med Hyg (1966) 1.25
RNA fingerprinting as a method for distinguishing dengue 1 virus strains. Am J Trop Med Hyg (1983) 1.25
Togaviridae. Intervirology (1978) 1.24
Comparison of dengue-2 and dengue-3 virus strains by neutralization tests and identification of a subtype of dengue-3. Am J Trop Med Hyg (1972) 1.23